These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 6130430)

  • 21. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
    Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
    Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
    Werz MA; Macdonald RL
    J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study on the effect of morphine and the opioid-like peptides in the vas deferens of rodents: species and strain differences, evidence for multiple opiate receptors.
    Huidobro-Toro JP; Way EL
    Life Sci; 1981 Mar; 28(12):1331-6. PubMed ID: 6264244
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enkephalin-inactivating enzymes].
    Oka T; Hiranuma T; Liu XF; Ohgiya N; Iwao K; Matsumiya T
    Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):197-207. PubMed ID: 8390390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Met5-enkephalin-Arg6-Phe7 inhibition of noradrenaline and acetylcholine release from peripheral organs.
    Hársing LG; Rónai AZ; Somogyi GT; Umezawa H; Bajusz S; Vizi ES
    J Auton Pharmacol; 1984 Mar; 4(1):33-43. PubMed ID: 6325463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the epsilon-type of opioid receptor in the rat vas deferens.
    Garzón J; Schulz R; Herz A
    Mol Pharmacol; 1985 Jul; 28(1):1-9. PubMed ID: 2991732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid receptor selectivity of peptide models of beta-endorphin.
    Taylor JW; Kaiser ET
    Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays.
    Sanchez-Blazquez P; Garzon J; Lee NM
    Eur J Pharmacol; 1984 Mar; 98(3-4):389-96. PubMed ID: 6327333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.